Related Experiment Video
Updated: Sep 4, 2025

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
Published on: January 20, 2023
Caspase-8 Blocks Receptor-Interacting Protein Kinase-1 Kinase-Independent Necroptosis during Embryogenesis
Haiwei Zhang1, Xiaoxia Wu1, Ming Li1
1CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
Abstract:
Caspase-8 (Casp8) suppresses receptor-interacting protein kinase-3 (RIPK3)/mixed lineage kinase domain-like protein (MLKL)-dependent necroptosis, demonstrated by the genetic evidence that deletion of Ripk3 or Mlkl prevented embryonic lethality of Casp8-deficient mice. However, the detailed mechanisms by which Casp8 deficiency triggers necroptosis during embryonic development remain unclear. In this article, we show that Casp8 deletion caused formation of the RIPK1-RIPK3 necrosome in the yolk sac, leading to vascularization defects, prevented by MLKL and RIPK3 deficiency, or RIPK3 RHIM mutant (RIPK3 V448P), but not by the RIPK1 kinase-dead mutant (RIPK1 K45A). In addition, Ripk1K45A/K45ACasp8 -/- mice died on embryonic day 14.5, which was delayed to embryonic day 17.5 by ablation of one allele in Ripk1 and was completely rescued by ablation of Mlkl Our results revealed an in vivo role of RIPK3 RHIM and RIPK1K45A scaffold-mediated necroptosis in Casp8 deficiency embryonic development and suggested that the Casp8-deficient yolk sac might be implicated in identifying novel regulators as an in vivo necroptotic model.
Insights
Caspase-8 (Casp8) deficiency triggers necroptosis during embryonic development by forming a RIPK1-RIPK3 necrosome in the yolk sac. This leads to vascularization defects, highlighting a crucial role for RIPK1 and RIPK3 in embryonic development.
Area of Science:
- Cellular Biology
- Developmental Biology
- Immunology
Background:
- Caspase-8 (Casp8) normally suppresses necroptosis, a form of programmed cell death mediated by RIPK3/MLKL.
- Genetic evidence shows that Ripk3 or Mlkl deficiency prevents embryonic lethality in Casp8-deficient mice.
- The precise mechanisms linking Casp8 deficiency to embryonic necroptosis remain largely unknown.
Purpose of the Study:
- To elucidate the molecular mechanisms by which Casp8 deficiency induces necroptosis during mouse embryonic development.
- To investigate the role of the RIPK1-RIPK3 necrosome in Casp8-deficient embryonic lethality and vascularization defects.
Main Methods:
- Genetic analysis of Casp8-deficient mice with targeted deletions or mutations in Ripk1, Ripk3, and Mlkl.
- Assessment of necrosome formation in yolk sac tissues.
- Evaluation of embryonic lethality and vascularization phenotypes.
Main Results:
- Casp8 deletion in mice led to RIPK1-RIPK3 necrosome formation in the yolk sac, causing vascularization defects.
- These defects were prevented by MLKL and RIPK3 deficiency or a RIPK3 RHIM mutant, but not by a RIPK1 kinase-dead mutant.
- Ripk1 deficiency caused embryonic lethality, which was delayed by heterozygous Ripk1 ablation and fully rescued by Mlkl ablation.
Conclusions:
- RIPK1 scaffold function and RIPK3 RHIM domain are critical for necroptosis in Casp8-deficient embryos.
- The Casp8-deficient yolk sac serves as a valuable in vivo model for studying necroptosis and identifying novel regulators.
Related Concept Videos
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Apoptosis

